Lymphokine activated effector cells for antibody-dependent...

Details Lymphokine activated effector cells for antibody-dependent... Lymphokine activated effector cells for antibody-dependent...

A - Human Necessities

61

K

167/139

A61K 39/395 (2006.01) A61K 35/12 (2006.01) A61K 35/14 (2006.01) A61K 35/28 (2006.01) A61K 39/44 (2006.01) C12N 1/36 (2006.01) C12N 1/38 (2006.01) A61K 38/00 (2006.01) C12N 5/06 (2006.01)

Patent

CA 1341303

This invention relates to processes and compositions for the immunotherapeutic treatment of cancer and non-malignant tumors. More particularly, this invention relates to processes and compositions for enhancing the body's immune response by increasing the cytotoxic activity of cells which mediate antibody dependent cellular cytotoxicity. Cells which are characterized by increased cytotoxic activity, as a result of the process of this invention, are useful compositions for the treatment of various types of cancer, non-malignant tumors, infections, and immune deficiencies.

512441

Affiliated with

Also associated with

Rating

Lymphokine activated effector cells for antibody-dependent... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lymphokine activated effector cells for antibody-dependent..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lymphokine activated effector cells for antibody-dependent... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1187384